Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.

Utility of Pro-calcitonin as an Indicator of Ischemia in Patients Undergoing Percutaneous Coronary Intervention With Subsequent Coronary Complications.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01609569

Enrollment

100

Registered

2012-06-01

Start date

2012-05-31

Completion date

2014-05-31

Last updated

2013-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease

Brief summary

The aim of this study is to determine on preliminary basis weather an elevated pro-calcitonin level can be used to assess ischemia as a result of coronary artery complications during percutaneous coronary intervention (PCI).

Detailed description

Pro-calcitonin is a type of protein found in the blood. This protein has recently be found to be elevated in patients with diseases of the arteries of the heart such as heart attack. Percutaneous coronary intervention (PCI) is widely used in the treatment of many patients with blockage in the arteries of the heart. the investigators normally used a marker called troponin after cardiac catheterization. However, this marker may not be specific. Pro-calcitonin has been found to be a useful marker for the detection of myocardial injury. the value of Pro-calcitonin as a marker for the identification of myocardial damage undergoing PCI has not yet been studied.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients older than 18 years old.

Exclusion criteria

* no consent. * suspicion of sepsis. * Patients with elevated troponin or procalcitonin before enrollment. * patients who had non-elective angioplasty (e.g. rescue angioplasty, primary angioplasty, salvage angioplasty, or emergency angioplasty)

Design outcomes

Primary

Measure	Time frame
Pro-calcitonin blood level	0,24 hours post cardiac intervention

Countries

United States

Outcome results